Zinc & Bone Health in Thalassemia: The Think Zinc Study

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

October 31, 2009

Study Completion Date

February 28, 2011

Conditions
Thalassemia
Interventions
DIETARY_SUPPLEMENT

Zinc

25 mg of elemental zinc as zinc sulphate take once daily for 18 months

DIETARY_SUPPLEMENT

Placebo

Placebo capsule, identical to the zn capsule in size, shape and color, taken once daily for 18 months

Trial Locations (3)

19104

Children's Hospital of Philadelphia, Philadelphia

94143

University of California, San Francisco, San Francisco

94609

Children's Hospital & Research Center, Oakland, Oakland

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Children's Hospital of Philadelphia

OTHER

collaborator

University of California, San Francisco

OTHER

lead

UCSF Benioff Children's Hospital Oakland

OTHER

NCT00459732 - Zinc & Bone Health in Thalassemia: The Think Zinc Study | Biotech Hunter | Biotech Hunter